Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Dyspnea | 48 | 2024 | 1352 | 6.560 |
Why?
|
Thinking | 11 | 2024 | 320 | 4.220 |
Why?
|
Education, Medical, Undergraduate | 15 | 2022 | 1081 | 3.570 |
Why?
|
Teaching | 21 | 2024 | 1174 | 3.240 |
Why?
|
Schools, Medical | 11 | 2022 | 881 | 2.420 |
Why?
|
Education, Medical | 17 | 2024 | 1742 | 2.390 |
Why?
|
Problem-Based Learning | 8 | 2020 | 356 | 2.320 |
Why?
|
Respiration, Artificial | 11 | 2024 | 2723 | 1.800 |
Why?
|
Curriculum | 22 | 2022 | 3778 | 1.720 |
Why?
|
Faculty, Medical | 11 | 2024 | 1218 | 1.560 |
Why?
|
Students, Medical | 15 | 2024 | 1962 | 1.530 |
Why?
|
Learning | 10 | 2024 | 1762 | 1.210 |
Why?
|
College Admission Test | 2 | 2020 | 11 | 1.140 |
Why?
|
Hypercapnia | 16 | 2017 | 260 | 1.100 |
Why?
|
Education, Dental | 3 | 2019 | 220 | 1.080 |
Why?
|
Clinical Competence | 11 | 2024 | 4841 | 1.020 |
Why?
|
Oxygen Inhalation Therapy | 4 | 2024 | 417 | 0.960 |
Why?
|
Uncertainty | 2 | 2020 | 758 | 0.860 |
Why?
|
Intensive Care Units | 12 | 2024 | 3805 | 0.850 |
Why?
|
School Admission Criteria | 2 | 2015 | 107 | 0.850 |
Why?
|
Work of Breathing | 6 | 2008 | 57 | 0.840 |
Why?
|
Respiration | 20 | 2020 | 1667 | 0.770 |
Why?
|
Education, Medical, Graduate | 7 | 2022 | 2411 | 0.760 |
Why?
|
Furosemide | 5 | 2019 | 171 | 0.760 |
Why?
|
Educational Measurement | 6 | 2020 | 1256 | 0.700 |
Why?
|
Neuroendocrine Cells | 1 | 2021 | 62 | 0.700 |
Why?
|
Opiate Alkaloids | 1 | 2020 | 28 | 0.700 |
Why?
|
Morphine | 2 | 2017 | 658 | 0.690 |
Why?
|
Internal Medicine | 5 | 2018 | 1056 | 0.680 |
Why?
|
Sodium Potassium Chloride Symporter Inhibitors | 4 | 2019 | 152 | 0.660 |
Why?
|
Pulmonary Ventilation | 5 | 2017 | 377 | 0.660 |
Why?
|
Government | 1 | 2020 | 162 | 0.650 |
Why?
|
Artificial Intelligence | 2 | 2024 | 2659 | 0.640 |
Why?
|
Psychological Theory | 1 | 2020 | 176 | 0.640 |
Why?
|
Physiology | 3 | 2021 | 112 | 0.630 |
Why?
|
Abdomen | 2 | 2020 | 1136 | 0.620 |
Why?
|
Research | 5 | 2017 | 1984 | 0.620 |
Why?
|
Cooperative Behavior | 3 | 2019 | 1514 | 0.610 |
Why?
|
Focus Groups | 2 | 2024 | 1448 | 0.600 |
Why?
|
Diagnostic Errors | 3 | 2024 | 1282 | 0.600 |
Why?
|
Nonverbal Communication | 1 | 2018 | 62 | 0.590 |
Why?
|
Consensus | 4 | 2022 | 3207 | 0.590 |
Why?
|
Concept Formation | 1 | 2019 | 162 | 0.580 |
Why?
|
Clinical Clerkship | 4 | 2022 | 566 | 0.580 |
Why?
|
Education, Distance | 1 | 2021 | 261 | 0.570 |
Why?
|
Human Rights | 1 | 2020 | 312 | 0.560 |
Why?
|
Respiratory Physiological Phenomena | 2 | 2017 | 192 | 0.560 |
Why?
|
Physicians | 3 | 2024 | 4615 | 0.550 |
Why?
|
Critical Care | 6 | 2024 | 2717 | 0.550 |
Why?
|
Academic Medical Centers | 5 | 2014 | 2785 | 0.550 |
Why?
|
Vibration | 4 | 2003 | 335 | 0.540 |
Why?
|
Pulmonary Medicine | 3 | 2015 | 223 | 0.540 |
Why?
|
Hypoaldosteronism | 1 | 2016 | 7 | 0.530 |
Why?
|
Fludrocortisone | 1 | 2016 | 24 | 0.530 |
Why?
|
Physician-Patient Relations | 4 | 2018 | 3267 | 0.520 |
Why?
|
Congresses as Topic | 3 | 2011 | 810 | 0.510 |
Why?
|
Acidosis, Renal Tubular | 1 | 2016 | 50 | 0.510 |
Why?
|
Lung | 8 | 2021 | 10090 | 0.490 |
Why?
|
Humans | 140 | 2024 | 768451 | 0.480 |
Why?
|
Sensation | 9 | 2022 | 337 | 0.470 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 6 | 2020 | 3246 | 0.470 |
Why?
|
Staff Development | 4 | 2017 | 230 | 0.470 |
Why?
|
Ventilator Weaning | 1 | 2015 | 170 | 0.470 |
Why?
|
Cognition | 5 | 2024 | 7066 | 0.450 |
Why?
|
Precancerous Conditions | 1 | 2021 | 988 | 0.450 |
Why?
|
Empathy | 2 | 2016 | 476 | 0.450 |
Why?
|
Enterocolitis, Pseudomembranous | 1 | 2016 | 264 | 0.440 |
Why?
|
Musculoskeletal Diseases | 1 | 2019 | 601 | 0.430 |
Why?
|
Rheumatology | 1 | 2019 | 619 | 0.430 |
Why?
|
Respiratory Mechanics | 7 | 2007 | 722 | 0.430 |
Why?
|
Oxygen | 6 | 2024 | 4269 | 0.420 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3116 | 0.410 |
Why?
|
Respiratory Muscles | 6 | 2003 | 144 | 0.400 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3240 | 0.400 |
Why?
|
Internship and Residency | 9 | 2018 | 5952 | 0.400 |
Why?
|
Group Processes | 3 | 2019 | 228 | 0.390 |
Why?
|
Carbon Dioxide | 9 | 2013 | 1152 | 0.390 |
Why?
|
Peer Review | 2 | 2016 | 217 | 0.390 |
Why?
|
Catheterization, Central Venous | 3 | 2015 | 530 | 0.390 |
Why?
|
Pulmonary Emphysema | 1 | 2017 | 690 | 0.390 |
Why?
|
Peer Review, Health Care | 1 | 2012 | 73 | 0.380 |
Why?
|
Intergenerational Relations | 1 | 2012 | 68 | 0.380 |
Why?
|
Communication | 5 | 2023 | 3910 | 0.370 |
Why?
|
Patient Simulation | 2 | 2010 | 297 | 0.350 |
Why?
|
Critical Illness | 3 | 2024 | 2754 | 0.350 |
Why?
|
Lung Diseases, Obstructive | 4 | 2001 | 311 | 0.340 |
Why?
|
Asthma | 10 | 2019 | 6274 | 0.340 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2013 | 497 | 0.340 |
Why?
|
Manometry | 2 | 2009 | 459 | 0.330 |
Why?
|
Problem Solving | 4 | 2024 | 443 | 0.320 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2010 | 169 | 0.320 |
Why?
|
Tidal Volume | 9 | 2020 | 515 | 0.320 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2020 | 2145 | 0.320 |
Why?
|
Delivery of Health Care | 3 | 2022 | 5367 | 0.300 |
Why?
|
Physical Exertion | 4 | 2021 | 669 | 0.300 |
Why?
|
Attitude of Health Personnel | 3 | 2013 | 3922 | 0.300 |
Why?
|
Pleural Effusion, Malignant | 1 | 2009 | 108 | 0.290 |
Why?
|
Self Report | 2 | 2016 | 3771 | 0.280 |
Why?
|
Fellowships and Scholarships | 2 | 2015 | 1134 | 0.280 |
Why?
|
Models, Educational | 5 | 2015 | 375 | 0.260 |
Why?
|
Patient-Centered Care | 3 | 2016 | 1439 | 0.260 |
Why?
|
Nurses | 1 | 2015 | 2494 | 0.260 |
Why?
|
Exhalation | 1 | 2006 | 185 | 0.250 |
Why?
|
Pleural Effusion | 1 | 2009 | 344 | 0.250 |
Why?
|
Thorax | 4 | 2001 | 559 | 0.250 |
Why?
|
Safety Management | 1 | 2011 | 764 | 0.250 |
Why?
|
Family | 1 | 2016 | 3208 | 0.240 |
Why?
|
Albuterol | 3 | 2017 | 211 | 0.240 |
Why?
|
Pressure | 3 | 2020 | 1173 | 0.230 |
Why?
|
Delphi Technique | 3 | 2022 | 879 | 0.230 |
Why?
|
Diagnosis, Differential | 5 | 2024 | 13026 | 0.230 |
Why?
|
Lung Neoplasms | 3 | 2021 | 13589 | 0.230 |
Why?
|
Emotions | 4 | 2020 | 2773 | 0.220 |
Why?
|
Teaching Rounds | 2 | 2021 | 280 | 0.220 |
Why?
|
Pandemics | 2 | 2020 | 8753 | 0.220 |
Why?
|
Hospitals, Teaching | 1 | 2008 | 1158 | 0.220 |
Why?
|
Respiratory Insufficiency | 3 | 2020 | 1244 | 0.210 |
Why?
|
Societies | 1 | 2023 | 107 | 0.200 |
Why?
|
Administration, Inhalation | 6 | 2019 | 1170 | 0.200 |
Why?
|
Health Occupations | 1 | 2024 | 225 | 0.200 |
Why?
|
Program Evaluation | 5 | 2021 | 2508 | 0.200 |
Why?
|
Male | 59 | 2024 | 364781 | 0.190 |
Why?
|
Ventilation-Perfusion Ratio | 1 | 2001 | 117 | 0.190 |
Why?
|
Hypoventilation | 1 | 2001 | 44 | 0.190 |
Why?
|
Thoracic Wall | 1 | 2003 | 204 | 0.180 |
Why?
|
New England | 1 | 2024 | 1056 | 0.180 |
Why?
|
Perception | 3 | 2024 | 1207 | 0.180 |
Why?
|
Bariatric Surgery | 1 | 2011 | 1007 | 0.180 |
Why?
|
Female | 53 | 2024 | 396943 | 0.180 |
Why?
|
Pain | 7 | 2024 | 5096 | 0.180 |
Why?
|
Quality of Health Care | 1 | 2016 | 4340 | 0.180 |
Why?
|
Early Detection of Cancer | 1 | 2015 | 3230 | 0.180 |
Why?
|
Pilot Projects | 7 | 2018 | 8730 | 0.180 |
Why?
|
Positive-Pressure Respiration | 3 | 2020 | 713 | 0.180 |
Why?
|
Kidney | 1 | 2016 | 7064 | 0.170 |
Why?
|
Bronchodilator Agents | 3 | 2012 | 519 | 0.170 |
Why?
|
Pulmonary Embolism | 4 | 2019 | 2591 | 0.170 |
Why?
|
Inhalation | 2 | 2017 | 145 | 0.170 |
Why?
|
Needs Assessment | 2 | 2020 | 1146 | 0.170 |
Why?
|
Hypernatremia | 1 | 2020 | 78 | 0.170 |
Why?
|
Health Personnel | 1 | 2014 | 3384 | 0.170 |
Why?
|
Bronchoconstriction | 1 | 2000 | 141 | 0.170 |
Why?
|
Inspiratory Capacity | 2 | 2017 | 35 | 0.170 |
Why?
|
Respiratory Therapy | 2 | 2016 | 125 | 0.160 |
Why?
|
Mass Screening | 1 | 2015 | 5455 | 0.160 |
Why?
|
Science | 1 | 2021 | 239 | 0.160 |
Why?
|
Narcotics | 1 | 2020 | 337 | 0.150 |
Why?
|
Vomiting | 2 | 2020 | 655 | 0.150 |
Why?
|
Tomography, X-Ray Computed | 3 | 2021 | 20762 | 0.150 |
Why?
|
Exercise Test | 3 | 2021 | 2186 | 0.150 |
Why?
|
Overweight | 1 | 2009 | 2428 | 0.150 |
Why?
|
Hyperplasia | 1 | 2021 | 1154 | 0.140 |
Why?
|
Diabetic Ketoacidosis | 1 | 2020 | 255 | 0.140 |
Why?
|
Respiratory Function Tests | 5 | 2023 | 1697 | 0.140 |
Why?
|
United States | 10 | 2023 | 73121 | 0.140 |
Why?
|
Radiography, Thoracic | 1 | 2003 | 1320 | 0.130 |
Why?
|
Adult | 42 | 2024 | 223542 | 0.130 |
Why?
|
Boston | 4 | 2016 | 9361 | 0.130 |
Why?
|
Mineralocorticoids | 1 | 2016 | 37 | 0.130 |
Why?
|
Analgesics, Opioid | 2 | 2012 | 3837 | 0.130 |
Why?
|
Diagnosis | 1 | 2016 | 156 | 0.130 |
Why?
|
Pulmonary Stretch Receptors | 3 | 2019 | 12 | 0.130 |
Why?
|
Pulmonary Gas Exchange | 2 | 2011 | 389 | 0.130 |
Why?
|
Medicine | 1 | 2024 | 946 | 0.130 |
Why?
|
Forced Expiratory Volume | 5 | 2002 | 1820 | 0.120 |
Why?
|
Students, Dental | 1 | 2017 | 172 | 0.120 |
Why?
|
Aerosols | 4 | 2019 | 637 | 0.120 |
Why?
|
Acid-Base Equilibrium | 1 | 2016 | 181 | 0.120 |
Why?
|
Quality Improvement | 3 | 2017 | 3858 | 0.120 |
Why?
|
Anxiety | 3 | 2020 | 4655 | 0.120 |
Why?
|
Evaluation Studies as Topic | 3 | 2012 | 1629 | 0.120 |
Why?
|
Inservice Training | 1 | 2017 | 377 | 0.120 |
Why?
|
Massachusetts | 3 | 2016 | 8908 | 0.120 |
Why?
|
Sodium Chloride | 1 | 2016 | 585 | 0.120 |
Why?
|
Biomedical Technology | 1 | 2016 | 210 | 0.110 |
Why?
|
Middle Aged | 28 | 2020 | 223418 | 0.110 |
Why?
|
Double-Blind Method | 8 | 2019 | 12450 | 0.110 |
Why?
|
Quadriplegia | 2 | 1992 | 226 | 0.110 |
Why?
|
Education, Nursing | 1 | 2014 | 83 | 0.110 |
Why?
|
Hyperkalemia | 1 | 2016 | 233 | 0.110 |
Why?
|
Cross-Over Studies | 4 | 2019 | 2103 | 0.110 |
Why?
|
Cost Control | 1 | 2016 | 627 | 0.110 |
Why?
|
Attitude to Health | 1 | 2002 | 2030 | 0.100 |
Why?
|
Medical Staff, Hospital | 1 | 2017 | 603 | 0.100 |
Why?
|
Vancomycin | 1 | 2016 | 506 | 0.100 |
Why?
|
Prospective Studies | 7 | 2022 | 54914 | 0.100 |
Why?
|
Professional Autonomy | 1 | 2013 | 172 | 0.100 |
Why?
|
Attitude | 1 | 2017 | 773 | 0.100 |
Why?
|
Feedback | 2 | 2016 | 794 | 0.100 |
Why?
|
Clinical Trials as Topic | 3 | 2024 | 8051 | 0.100 |
Why?
|
Aged | 17 | 2023 | 171520 | 0.100 |
Why?
|
Accreditation | 1 | 2015 | 478 | 0.100 |
Why?
|
Telecommunications | 1 | 2012 | 79 | 0.100 |
Why?
|
Peer Group | 1 | 2017 | 697 | 0.100 |
Why?
|
Lung Diseases | 4 | 1996 | 1926 | 0.090 |
Why?
|
Bronchial Provocation Tests | 2 | 2002 | 216 | 0.090 |
Why?
|
Professional Competence | 1 | 2014 | 431 | 0.090 |
Why?
|
Patient Admission | 1 | 2018 | 1370 | 0.090 |
Why?
|
Spirometry | 4 | 2012 | 928 | 0.090 |
Why?
|
Neurobiology | 1 | 2011 | 138 | 0.090 |
Why?
|
Pain Measurement | 4 | 2022 | 3577 | 0.090 |
Why?
|
Ethics Committees, Research | 1 | 2011 | 196 | 0.080 |
Why?
|
Students | 1 | 2020 | 1751 | 0.080 |
Why?
|
Workflow | 1 | 2014 | 861 | 0.080 |
Why?
|
Fatigue | 2 | 2013 | 1556 | 0.080 |
Why?
|
Language | 1 | 1998 | 1557 | 0.080 |
Why?
|
Diarrhea | 1 | 2016 | 1320 | 0.080 |
Why?
|
Biopsy | 1 | 2021 | 6816 | 0.080 |
Why?
|
Pathology, Clinical | 1 | 2012 | 377 | 0.080 |
Why?
|
Masks | 1 | 1991 | 215 | 0.080 |
Why?
|
Mouth Mucosa | 1 | 1991 | 437 | 0.080 |
Why?
|
Obesity | 1 | 2011 | 13065 | 0.080 |
Why?
|
Ambulatory Care Facilities | 1 | 2014 | 941 | 0.080 |
Why?
|
Elasticity | 2 | 2009 | 658 | 0.080 |
Why?
|
Paracentesis | 1 | 2009 | 99 | 0.080 |
Why?
|
Health Facility Administrators | 1 | 2008 | 32 | 0.080 |
Why?
|
Acute Disease | 3 | 2006 | 7246 | 0.070 |
Why?
|
Canada | 1 | 2013 | 2143 | 0.070 |
Why?
|
Sodium Glutamate | 1 | 1987 | 24 | 0.070 |
Why?
|
Guideline Adherence | 2 | 2015 | 2239 | 0.070 |
Why?
|
Patient Readmission | 1 | 2021 | 3308 | 0.070 |
Why?
|
Reproducibility of Results | 6 | 2018 | 20231 | 0.070 |
Why?
|
Social Environment | 1 | 2012 | 1026 | 0.070 |
Why?
|
Quality Control | 1 | 2009 | 835 | 0.070 |
Why?
|
Cryotherapy | 1 | 1987 | 160 | 0.070 |
Why?
|
Radiation Dosage | 1 | 2015 | 1973 | 0.070 |
Why?
|
Angiography | 1 | 2011 | 1598 | 0.070 |
Why?
|
Body Weights and Measures | 1 | 2006 | 208 | 0.070 |
Why?
|
Nifedipine | 1 | 1986 | 220 | 0.070 |
Why?
|
Terminal Care | 1 | 2018 | 1773 | 0.060 |
Why?
|
Interprofessional Relations | 2 | 2011 | 997 | 0.060 |
Why?
|
Patient Participation | 1 | 2015 | 1450 | 0.060 |
Why?
|
Advisory Committees | 1 | 2010 | 797 | 0.060 |
Why?
|
Observer Variation | 1 | 2012 | 2622 | 0.060 |
Why?
|
Analysis of Variance | 2 | 2006 | 6242 | 0.060 |
Why?
|
Disease Progression | 1 | 2023 | 13655 | 0.060 |
Why?
|
Glutamates | 1 | 1987 | 385 | 0.060 |
Why?
|
Air Pressure | 2 | 2003 | 75 | 0.060 |
Why?
|
Interviews as Topic | 1 | 2013 | 2733 | 0.060 |
Why?
|
Echocardiography | 1 | 2018 | 5043 | 0.060 |
Why?
|
Oxygen Consumption | 1 | 2012 | 1882 | 0.060 |
Why?
|
Organizational Innovation | 1 | 2008 | 540 | 0.060 |
Why?
|
Decision Making | 1 | 2019 | 3961 | 0.060 |
Why?
|
Treatment Outcome | 4 | 2020 | 65409 | 0.060 |
Why?
|
Aged, 80 and over | 6 | 2019 | 59680 | 0.060 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2010 | 4049 | 0.060 |
Why?
|
Research Design | 1 | 2020 | 6217 | 0.060 |
Why?
|
Sepsis | 1 | 2018 | 2602 | 0.060 |
Why?
|
Monitoring, Physiologic | 1 | 2011 | 1795 | 0.060 |
Why?
|
Heart Failure | 2 | 2006 | 11857 | 0.060 |
Why?
|
Research Support as Topic | 1 | 2008 | 699 | 0.060 |
Why?
|
Activities of Daily Living | 1 | 2013 | 2433 | 0.060 |
Why?
|
Health Services Research | 1 | 2011 | 1815 | 0.060 |
Why?
|
Mechanoreceptors | 3 | 1995 | 194 | 0.050 |
Why?
|
Hemangiosarcoma | 1 | 2005 | 216 | 0.050 |
Why?
|
Hyperventilation | 1 | 2003 | 78 | 0.050 |
Why?
|
Program Development | 1 | 2009 | 1296 | 0.050 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2020 | 4636 | 0.050 |
Why?
|
Ventilation | 1 | 2003 | 129 | 0.050 |
Why?
|
Exercise Tolerance | 1 | 2007 | 849 | 0.050 |
Why?
|
Feasibility Studies | 1 | 2013 | 5308 | 0.050 |
Why?
|
Intercostal Muscles | 1 | 2001 | 26 | 0.050 |
Why?
|
Heart Neoplasms | 1 | 2005 | 374 | 0.050 |
Why?
|
Breath Tests | 1 | 2003 | 300 | 0.050 |
Why?
|
Reference Values | 2 | 2006 | 4941 | 0.050 |
Why?
|
Functional Residual Capacity | 2 | 1992 | 70 | 0.050 |
Why?
|
Osteoporosis | 1 | 2011 | 1606 | 0.050 |
Why?
|
Oscillometry | 1 | 2001 | 150 | 0.050 |
Why?
|
Manikins | 2 | 2015 | 254 | 0.040 |
Why?
|
Bronchoconstrictor Agents | 1 | 2000 | 77 | 0.040 |
Why?
|
Depression | 1 | 2020 | 8235 | 0.040 |
Why?
|
Patient Education as Topic | 1 | 2011 | 2339 | 0.040 |
Why?
|
Exercise | 3 | 1999 | 5940 | 0.040 |
Why?
|
Vital Capacity | 2 | 2002 | 984 | 0.040 |
Why?
|
Sternum | 1 | 2001 | 177 | 0.040 |
Why?
|
Methacholine Chloride | 1 | 2000 | 220 | 0.040 |
Why?
|
Affect | 1 | 2008 | 1498 | 0.040 |
Why?
|
Palliative Care | 3 | 2022 | 3644 | 0.040 |
Why?
|
Lung Volume Measurements | 3 | 1999 | 383 | 0.040 |
Why?
|
Longitudinal Studies | 2 | 2018 | 14766 | 0.040 |
Why?
|
Osmolar Concentration | 1 | 2020 | 659 | 0.040 |
Why?
|
Hospitalization | 1 | 2019 | 10845 | 0.040 |
Why?
|
Models, Biological | 3 | 2017 | 9505 | 0.040 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2009 | 1427 | 0.040 |
Why?
|
Pharynx | 1 | 2001 | 436 | 0.040 |
Why?
|
Death | 1 | 2023 | 683 | 0.040 |
Why?
|
Pulmonary Circulation | 1 | 2001 | 744 | 0.040 |
Why?
|
Vasoconstriction | 1 | 2001 | 594 | 0.040 |
Why?
|
Length of Stay | 2 | 2021 | 6521 | 0.040 |
Why?
|
Severity of Illness Index | 4 | 2018 | 15965 | 0.040 |
Why?
|
Age Factors | 2 | 2012 | 18478 | 0.040 |
Why?
|
Naloxone | 2 | 1992 | 371 | 0.040 |
Why?
|
Nebulizers and Vaporizers | 1 | 1998 | 139 | 0.040 |
Why?
|
Mental Recall | 2 | 2011 | 1226 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2015 | 7451 | 0.040 |
Why?
|
Time Factors | 4 | 2018 | 40271 | 0.040 |
Why?
|
Risk Factors | 3 | 2020 | 74915 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2020 | 13708 | 0.040 |
Why?
|
Dextrans | 1 | 1999 | 574 | 0.030 |
Why?
|
Anti-Bacterial Agents | 1 | 2016 | 7471 | 0.030 |
Why?
|
Multivariate Analysis | 1 | 2010 | 12096 | 0.030 |
Why?
|
Risk Assessment | 2 | 2015 | 24311 | 0.030 |
Why?
|
Internet | 1 | 2008 | 3123 | 0.030 |
Why?
|
Chemoreceptor Cells | 1 | 1995 | 88 | 0.030 |
Why?
|
Neuromuscular Diseases | 2 | 1995 | 262 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2013 | 22293 | 0.030 |
Why?
|
Cluster Analysis | 3 | 2000 | 2731 | 0.030 |
Why?
|
Patient Satisfaction | 2 | 1998 | 3484 | 0.030 |
Why?
|
Muscles | 2 | 1991 | 1582 | 0.030 |
Why?
|
Attitude to Death | 1 | 2018 | 401 | 0.030 |
Why?
|
Sodium | 1 | 2020 | 1595 | 0.030 |
Why?
|
Exercise Therapy | 2 | 2012 | 941 | 0.030 |
Why?
|
Electromyography | 5 | 1992 | 1399 | 0.030 |
Why?
|
Ventilators, Mechanical | 1 | 2016 | 292 | 0.030 |
Why?
|
Random Allocation | 3 | 1989 | 2399 | 0.030 |
Why?
|
Partial Pressure | 2 | 1999 | 247 | 0.030 |
Why?
|
Airway Obstruction | 1 | 1998 | 672 | 0.030 |
Why?
|
Sleep Medicine Specialty | 1 | 2014 | 72 | 0.030 |
Why?
|
Computer Simulation | 1 | 2007 | 6278 | 0.030 |
Why?
|
Terminology as Topic | 1 | 2000 | 1539 | 0.030 |
Why?
|
Adolescent | 5 | 2023 | 89168 | 0.030 |
Why?
|
Placebo Effect | 1 | 2016 | 518 | 0.030 |
Why?
|
Lidocaine | 2 | 1997 | 545 | 0.030 |
Why?
|
Mentors | 1 | 2017 | 672 | 0.020 |
Why?
|
Prevalence | 2 | 2019 | 15880 | 0.020 |
Why?
|
Chest Pain | 1 | 1998 | 1099 | 0.020 |
Why?
|
Body Mass Index | 1 | 2009 | 13030 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2006 | 14728 | 0.020 |
Why?
|
Plethysmography | 1 | 1991 | 174 | 0.020 |
Why?
|
Models, Anatomic | 1 | 2015 | 684 | 0.020 |
Why?
|
Lung Diseases, Interstitial | 1 | 2019 | 935 | 0.020 |
Why?
|
Appointments and Schedules | 1 | 2014 | 443 | 0.020 |
Why?
|
Surgical Flaps | 1 | 1999 | 1683 | 0.020 |
Why?
|
Efficiency, Organizational | 1 | 2014 | 699 | 0.020 |
Why?
|
Maximal Voluntary Ventilation | 1 | 1989 | 14 | 0.020 |
Why?
|
Subclavian Vein | 1 | 2009 | 57 | 0.020 |
Why?
|
Interpersonal Relations | 1 | 2017 | 1439 | 0.020 |
Why?
|
Mouth Breathing | 1 | 1989 | 24 | 0.020 |
Why?
|
Arousal | 2 | 1992 | 1182 | 0.020 |
Why?
|
Research Subjects | 1 | 2011 | 249 | 0.020 |
Why?
|
Anesthesia, Local | 1 | 1991 | 278 | 0.020 |
Why?
|
Factor Analysis, Statistical | 1 | 2012 | 1007 | 0.020 |
Why?
|
Mammaplasty | 1 | 1999 | 1262 | 0.020 |
Why?
|
Oximetry | 1 | 2012 | 462 | 0.020 |
Why?
|
Retrospective Studies | 4 | 2021 | 81834 | 0.020 |
Why?
|
Advance Care Planning | 1 | 2016 | 698 | 0.020 |
Why?
|
Abdominal Muscles | 1 | 1989 | 172 | 0.020 |
Why?
|
Skin Diseases, Vesiculobullous | 1 | 1989 | 85 | 0.020 |
Why?
|
Follow-Up Studies | 3 | 2011 | 39430 | 0.020 |
Why?
|
Psychophysiology | 1 | 2008 | 137 | 0.020 |
Why?
|
Tongue | 1 | 1991 | 406 | 0.020 |
Why?
|
Hemoptysis | 1 | 1989 | 152 | 0.020 |
Why?
|
Physical Fitness | 1 | 1992 | 744 | 0.020 |
Why?
|
Career Choice | 1 | 2014 | 769 | 0.020 |
Why?
|
Brain Stem | 1 | 1992 | 862 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2021 | 5371 | 0.020 |
Why?
|
Nasopharynx | 1 | 1990 | 420 | 0.020 |
Why?
|
Pemphigoid, Bullous | 1 | 1989 | 113 | 0.020 |
Why?
|
Sleep Stages | 1 | 1991 | 702 | 0.020 |
Why?
|
Emergency Medical Services | 1 | 2018 | 1948 | 0.020 |
Why?
|
Sleep Apnea Syndromes | 2 | 1992 | 981 | 0.020 |
Why?
|
Blood Glucose | 1 | 2020 | 6429 | 0.020 |
Why?
|
Psychometrics | 1 | 2015 | 3072 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2017 | 10784 | 0.020 |
Why?
|
Anesthesia, General | 1 | 1992 | 1185 | 0.020 |
Why?
|
Chronic Disease | 1 | 2019 | 9382 | 0.010 |
Why?
|
Child | 2 | 2010 | 80863 | 0.010 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2005 | 353 | 0.010 |
Why?
|
Perioperative Care | 1 | 2012 | 1046 | 0.010 |
Why?
|
Reward | 1 | 2011 | 987 | 0.010 |
Why?
|
Models, Psychological | 1 | 2008 | 835 | 0.010 |
Why?
|
Ascites | 1 | 2005 | 339 | 0.010 |
Why?
|
Anticoagulants | 1 | 1999 | 4840 | 0.010 |
Why?
|
Pericardial Effusion | 1 | 2005 | 246 | 0.010 |
Why?
|
Comorbidity | 1 | 2018 | 10601 | 0.010 |
Why?
|
Adrenal Cortex Hormones | 1 | 2012 | 1891 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 2020 | 6400 | 0.010 |
Why?
|
Databases, Factual | 1 | 2018 | 8081 | 0.010 |
Why?
|
Edema | 1 | 2005 | 766 | 0.010 |
Why?
|
Memory | 1 | 2011 | 2210 | 0.010 |
Why?
|
Face | 1 | 1987 | 1031 | 0.010 |
Why?
|
Subject Headings | 1 | 2000 | 17 | 0.010 |
Why?
|
Pericardium | 1 | 2005 | 679 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2005 | 1840 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 2020 | 6978 | 0.010 |
Why?
|
Airway Resistance | 2 | 1991 | 406 | 0.010 |
Why?
|
Sleep | 2 | 1992 | 4796 | 0.010 |
Why?
|
Heart Atria | 1 | 2005 | 1361 | 0.010 |
Why?
|
Echocardiography, Transesophageal | 1 | 2005 | 1095 | 0.010 |
Why?
|
Food Hypersensitivity | 1 | 1987 | 737 | 0.010 |
Why?
|
Blood Pressure | 2 | 1992 | 8538 | 0.010 |
Why?
|
Child, Preschool | 1 | 2021 | 42623 | 0.010 |
Why?
|
Administration, Oral | 1 | 1986 | 4041 | 0.010 |
Why?
|
Hemorrhage | 1 | 1989 | 3458 | 0.010 |
Why?
|
Postoperative Complications | 1 | 1999 | 15880 | 0.010 |
Why?
|
Cerebral Cortex | 1 | 1992 | 5827 | 0.010 |
Why?
|
Cohort Studies | 1 | 1998 | 41797 | 0.010 |
Why?
|
Stress, Psychological | 1 | 2011 | 4538 | 0.010 |
Why?
|
Physical Stimulation | 1 | 1997 | 517 | 0.010 |
Why?
|
Fiber Optic Technology | 1 | 1997 | 291 | 0.010 |
Why?
|
Incidence | 1 | 2013 | 21552 | 0.010 |
Why?
|
Radiography | 1 | 2005 | 6995 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 1999 | 2228 | 0.010 |
Why?
|
Educational Status | 1 | 2000 | 2519 | 0.010 |
Why?
|
Pressoreceptors | 1 | 1992 | 99 | 0.010 |
Why?
|
Hypertension | 1 | 1992 | 8611 | 0.010 |
Why?
|
Catheterization | 1 | 1997 | 1431 | 0.010 |
Why?
|
Phenylephrine | 1 | 1992 | 294 | 0.010 |
Why?
|
Thermoreceptors | 1 | 1990 | 27 | 0.010 |
Why?
|
Bronchoscopy | 1 | 1997 | 913 | 0.010 |
Why?
|
Young Adult | 1 | 2017 | 60045 | 0.010 |
Why?
|
Total Lung Capacity | 1 | 1990 | 149 | 0.010 |
Why?
|
Anesthetics, Local | 1 | 1997 | 1005 | 0.010 |
Why?
|
Neurons, Afferent | 1 | 1992 | 498 | 0.010 |
Why?
|
Prognosis | 1 | 2010 | 30028 | 0.010 |
Why?
|
Humidity | 1 | 1990 | 206 | 0.010 |
Why?
|
Snoring | 1 | 1990 | 209 | 0.000 |
Why?
|
Respiratory System | 1 | 1992 | 565 | 0.000 |
Why?
|
Electrodes | 1 | 1991 | 618 | 0.000 |
Why?
|
Apnea | 1 | 1989 | 195 | 0.000 |
Why?
|
Acoustic Stimulation | 1 | 1992 | 1253 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2012 | 36840 | 0.000 |
Why?
|
Temperature | 1 | 1990 | 2237 | 0.000 |
Why?
|
Electrocardiography | 1 | 1997 | 6410 | 0.000 |
Why?
|
Hypertension, Pulmonary | 1 | 1990 | 1605 | 0.000 |
Why?
|
Anesthesia | 1 | 1990 | 1596 | 0.000 |
Why?
|
Animals | 1 | 2011 | 169418 | 0.000 |
Why?
|
Heart Diseases | 1 | 1990 | 2816 | 0.000 |
Why?
|
Electroencephalography | 1 | 1992 | 6309 | 0.000 |
Why?
|
Pregnancy | 1 | 1990 | 30179 | 0.000 |
Why?
|